Rosuvastatin--a highly effective new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor: review of clinical trial data at 10-40 mg doses in dyslipidemic patients (Q30806573)
scientific article
Language:
Current Data About Rosuvastatin--a highly effective new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor: review of clinical trial data at 10-40 mg doses in dyslipidemic patients
(P31) (Q13442814)
(P248)
(P698) 12824720
(P813) Monday, June 26, 2017

(P304) 126-139
(P248)
(P698) 12824720
(P813) Monday, June 26, 2017

(P407) (Q1860)

(P433) 3
(P248)
(P698) 12824720
(P813) Monday, June 26, 2017

(P478) 99
(P248)
(P698) 12824720
(P813) Monday, June 26, 2017

(P577) Wednesday, January 1, 2003
(P248)
(P698) 12824720
(P813) Monday, June 26, 2017

(P1433) (Q2404578)
(P248)
(P698) 12824720
(P813) Monday, June 26, 2017

(P1476) "Rosuvastatin--a highly effective new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor: review of clinical trial data at 10-40 mg doses in dyslipidemic patients" (language: en)
(P248)
(P698) 12824720
(P813) Monday, June 26, 2017

(P2093) Herbert Schuster
(P1545) 1
(P248)
(P698) 12824720
(P813) Monday, June 26, 2017

other details
description scientific article

External Links
(P356) 10.1159/000070669
(P698) 12824720